Dose conversion ratio, comparative efficacy, and adverse events after switching from onabotulinum toxin A to abobotulinum toxin A for neurological conditions-Reference-Cited by-同舟云学术

Dose conversion ratio, comparative efficacy, and adverse events after switching from onabotulinum toxin A to abobotulinum toxin A for neurological conditions

Published:2021-10 Issue: Volume:209 Page:106889
ISSN:0303-8467
Container-title:Clinical Neurology and Neurosurgery
language:en
Short-container-title:Clinical Neurology and Neurosurgery

Author:

Ozer Incı Sule,Kuzu Kumcu Muge,Tezcan Aydemir Sabiha,Akbostanci Muhittin Cenk

Publisher

Elsevier BV

Subject

Clinical Neurology,General Medicine,Surgery

Reference12 articles.

1. Dysport produces intrinsically more swallowing problems than Botox: unexpected results from a conversion factor study in cervical dystonia;Dressler;J. Neurol., Neurosurg. Psychiatry,2002

2. Dose standardisation of botulinum toxin;Marion;J. Neurol., Neurosurg. Psychiatry,1995

3. Immunological aspects of Botox®, Dysport® and Myobloc/Neurobloc®, Eur;Dressler;J. Neurol.,2006

4. Retrospective evaluation of the dose of Dysport and BOTOX in the management of cervical dystonia and blepharospasm: the REAL DOSE study;Marchetti;Mov. Disord.,2005

5. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm;Bihari;Curr. Med. Res. Opin.,2005

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Botulinum Toxin Treatment in Blepharospasm: Single-center Experience;Turkish Journal Of Neurology;2023-10-02

2. A UK Single-Center, Retrospective, Noninterventional Study of Clinical Outcomes and Costs of Two BotulinumtoxinA Treatments for Limb Spasticity;Toxins;2023-08-30

3. Botulinum Toxin for the Treatment of Hemifacial Spasm: An Update on Clinical Studies;Toxins;2021-12-09